The The7 — Website and eCommerce Builder for WordPress theme for WordPress is vulnerable to Stored Cross-Site Scripting via the ‘ the7_fancy_title_css’ parameter in all versions up to, and including, 12.9.1 due to insufficient input sanitization and output escaping. This makes it possible for authenticated attackers, with Contributor-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.
CVE-2025-11897 is a medium severity with CVSS 6.4 Stored Cross-Site Scripting issue affecting the Theme The7 — Website and eCommerce Builder for WordPress. It affects Versions up to 12.9.1 and is fixed in 12.9.2.
Use the related hub and response guides to connect this CVE-2025-11897 report with patch validation, scanner checks, and site hardening work.
Open the grouped hub for related CVEs, affected ranges, severity mix, and patch coverage.
Check access, XML-RPC exposure, backup readiness, and monitoring after patching.
Use containment, evidence capture, remediation, and validation steps when exploit risk is high.
CVE-2025-11897 is tracked for the Theme The7 — Website and eCommerce Builder for WordPress as medium severity with CVSS 6.4. The affected range is Versions up to 12.9.1. Update The7 — Website and eCommerce Builder for WordPress to 12.9.2 or newer where that version is compatible with the site.
Search engines and operators need more than a title. This page exposes the identifier, affected range, patch evidence, and source coverage that make the vulnerability actionable.
This report has a CVE identifier, which makes it suitable for focused search and vulnerability triage workflows.
Affected version data gives operators a concrete comparison point against installed WordPress software.
A fixed version is present, so the page can answer update and remediation intent directly.
External references are available for source validation, advisory review, and incident notes.
Use these checks when converting this record into a patch ticket, incident note, or risk acceptance decision.
Inventory the installed Theme package and compare its version with Versions up to 12.9.1.
Confirm The7 — Website and eCommerce Builder for WordPress is updated to 12.9.2 or newer.
Review references and CVSS vector details for exploitability, authentication requirements, and exposure path.
After patching, re-run vulnerability monitoring and keep the related plugin or theme hub under review for follow-up CVEs.
| Software Type | Theme |
|---|---|
| Software Slug |
dt-the7
View on wordpress.org
|
| CVE | CVE-2025-11897 |
| Patched Versions |
12.9.2
|
| Affected Versions |
Versions up to 12.9.1
|
These internal links group the same WordPress theme by CVE, issue type, severity, and patch status so operators and search engines can connect the full vulnerability cluster.
The7 < 12.8.1.1 - Authenticated (Contributor+) Local File Inclusion
The7 <= 14.3.2 - Authenticated (Contributor+) Stored Cross-Site Scripting via Shortcode 'link' Parameter
The7 < 12.9.0 - Authenticated (Contributor+) Stored Cross-Site Scripting
The7 <= 12.6.0 - Authenticated (Contributor+) Stored Cross-Site Scripting via title and data-dt-img-description Attributes
The7 — Website and eCommerce Builder for WordPress <= 11.13.0 - Authenticated (Contributor+) Stored Cross-Site Scripting via url Attribute
The7 <= 11.6.0 - Reflected Cross-Site Scripting
The7 <= 11.7.3 - Cross-Site Request Forgery
The7 — Website and eCommerce Builder for WordPress <= 2.1.0 - Reflected Cross-Site Scripting
This record contains material that is subject to copyright
License: Defiant hereby grants you a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable copyright license to reproduce, prepare derivative works of, publicly display, publicly perform, sublicense, and distribute this software vulnerability information. Any copy of the software vulnerability information you make for such purposes is authorized provided that you include a hyperlink to this vulnerability record and reproduce Defiant's copyright designation and this license in any such copy. Read more
License: CVE Usage: MITRE hereby grants you a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable copyright license to reproduce, prepare derivative works of, publicly display, publicly perform, sublicense, and distribute Common Vulnerabilities and Exposures (CVE®). Any copy you make for such purposes is authorized provided that you reproduce MITRE's copyright designation and this license in any such copy. Read more
